Hydroxamic acid derivatives as inhibitors of cytokine production
    92.
    发明授权
    Hydroxamic acid derivatives as inhibitors of cytokine production 失效
    羟肟酸衍生物作为细胞因子产生的抑制剂

    公开(公告)号:US5821262A

    公开(公告)日:1998-10-13

    申请号:US615184

    申请日:1996-10-28

    摘要: A compound of formula (I): ##STR1## wherein: R.sup.1 represents a (C.sub.1 -C.sub.6)alkyl, phenyl, substituted phenyl, or heterocyclyl group; R.sup.2 represents a (C.sub.1 -C.sub.6)alkyl group; R.sup.3 represents: (I) the side chain of arginine, lysine, tryptophan, histidine, serine, threonine, or cysteine, in which any polar amino, hydroxy, mercapto, guanidyl, imidazolyl or indolyl group is rendered substantially non-polar by substitution at the polar N-, O- or S-atom; or (ii) the side chain of aspartic or glutamic acid, in which side chain the carboxylic acid group is amidated; R.sup.4 represents hydrogen or a (C.sub.1 -C.sub.6)alkyl or phenyl (C.sub.1 -C.sub.6)alkyl group; R.sup.5 represents hydrogen or and n is 0, 1 or 2; or substituted phenyl groups; or a salt solvate or hydrate thereof. Compositions containing compound (I) and methods for treatment of diseases or conditions mediated by TNF or MMPs in mammals.

    摘要翻译: PCT No.PCT / GB94 / 02145 Sec。 371日期1996年10月28日第 102(e)日期1996年10月28日PCT 1994年10月4日PCT PCT。 第WO95 / 09841号公报 日期:1995年4月13日一种式(I)化合物:其中:R1表示(C1-C6)烷基,苯基,取代的苯基或杂环基; R2表示(C1-C6)烷基; R3表示:(I)精氨酸,赖氨酸,色氨酸,组氨酸,丝氨酸,苏氨酸或半胱氨酸的侧链,其中任何极性氨基,羟基,巯基,胍基,咪唑基或吲哚基基本上通过在 极性N-,O-或S-原子; 或(ii)天冬氨酸或谷氨酸的侧链,其中侧链羧酸基团被酰胺化; R4表示氢或(C1-C6)烷基或苯基(C1-C6)烷基; R5表示氢,n表示0,1或2; 或取代的苯基; 或其盐溶剂化物或其水合物。 含有化合物(I)的组合物和用于治疗哺乳动物中TNF或MMP介导的疾病或病症的方法。